Dealmaking continues in the in vitro diagnostics (IVD) industry as AI-driven genomics and private equity reshape the market for a data-first future. On Nov. 4, Qiagen said it will acquire Parse Biosciences for $280 million to expand its reach into single-cell sequencing, leveraging Parse’s Evercode technology and vast datasets to power AI-enabled drug discovery. This […]
November 17, 2025, Intelligence: Late-Breaking Lab News
- By Robert Michel
- > From the Volume XXXII, No. 16 - November 17, 2025 Issue
- Tags: AI, artificial intelligence, Blackstone, California Department of Public Health, clinical laboratory scientist, CLS, COC, College of the Canyons, CSI Laboratories, Dark Daily, Evercode, genomics, Heather Creran, Hencelyn Chu PhD, in vitro diagnostics, Inflo Health, IVD, Lineagen, OncoLens, Parse Biosciences, Paul Staats MD, precision medicine, Private equity, Qiagen, Siemens, single-cell sequencing, TPG, University of Maryland Medical Center, University of Maryland School of Medicine
